NCT04095013

Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section

Comparative Evaluation of Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Dow University of Health Sciences · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

the primary objective of the study is to compare the onset and recovery times of sensory and motor blockade of the two study drugs intrathecally with low dose bupivacaine The secondary objectives of the study are to observe hemodynamics, side effects profile, and duration of postoperative analgesia

Detailed description

The current study is undertaken to compare the effect of two drugs intrathecally.edexmedetomidine and fentanyl with a low dose of bupivacaine and assess the adequacy of the block, side effect profile and postoperative analgesia. The two drugs have been studied separately but the comparative data is scarcely available both at national and international level. A particular agent is a dexmedetomidine that has been introduced in the investiagator's setup for the first time so this research will be of great importance in adding its multiple uses other than being used as ICU and procedural sedation agent.

Conditions

• Cesarean Section Complications

Interventions

Type	Name	Description
DRUG	Bupivacaine, fentanyl	Group A: hyperbaric Bupivacaine 10mg with fentanyl 10micrograms,
DRUG	Bupivacaine, dexmedetomidine	Group B: hyperbaric Bupivacaine 10 mg with dexmedetomidine5 micrograms

Timeline

• Start date: 2019-02-01
• Primary completion: 2019-06-15
• Completion: 2019-07-15
• First posted: 2019-09-19
• Last updated: 2019-09-19

Locations

2 sites across 1 country: Pakistan